Affluent Medical SA
EPA:AFME.PA
1.845 (EUR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 1.658 | 2.58 | 11.41 | 5.65 | 2.126 | 4.875 | 1.63 |
Short Term Investments
| 0 | -0.035 | -0.117 | -0.078 | 0 | 0 | 0 |
Cash and Short Term Investments
| 1.658 | 2.58 | 11.41 | 5.65 | 2.126 | 4.875 | 1.63 |
Net Receivables
| 3.401 | 4.048 | 2.893 | 1.972 | 3.599 | 3.964 | 2.057 |
Inventory
| 0 | 0 | 0 | 0.29 | 0 | 0.731 | 0.189 |
Other Current Assets
| 0.734 | 0.553 | 0.372 | -0.001 | 0.391 | -0.002 | 0.001 |
Total Current Assets
| 5.793 | 7.181 | 14.675 | 7.911 | 6.116 | 9.568 | 3.877 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 1.596 | 1.755 | 2.006 | 1.781 | 1.746 | 0.263 | 0.089 |
Goodwill
| 32.203 | 32.203 | 32.203 | 32.203 | 32.203 | 55.718 | 55.718 |
Intangible Assets
| 16.987 | 18.821 | 20.695 | 22.566 | 56.645 | 1.822 | 2.022 |
Goodwill and Intangible Assets
| 49.19 | 51.024 | 52.898 | 54.769 | 88.848 | 57.54 | 57.74 |
Long Term Investments
| 0.018 | 0.061 | 0.457 | 0.365 | 0.745 | 0.022 | 0.015 |
Tax Assets
| 16.987 | -0.061 | -0.457 | -0.365 | 26.602 | -0.022 | -0.015 |
Other Non-Current Assets
| -16.961 | 0.06 | 0.456 | 0.365 | -58.805 | 0.044 | 0.015 |
Total Non-Current Assets
| 50.83 | 52.839 | 55.36 | 56.915 | 59.136 | 57.825 | 57.844 |
Total Assets
| 56.623 | 60.02 | 70.035 | 64.826 | 65.252 | 67.393 | 61.721 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 3.373 | 3.02 | 1.793 | 2.352 | 3.704 | 2.043 | 1.76 |
Short Term Debt
| 2.077 | 2.062 | 2.753 | 3.801 | 3.492 | 0 | 0 |
Tax Payables
| 0.112 | 3.075 | 2.168 | 1.473 | 0.018 | 0.509 | 0.685 |
Deferred Revenue
| 0.08 | 0 | 2.487 | 3.174 | 0.409 | 0 | 0 |
Other Current Liabilities
| 2.888 | 3.554 | 0.27 | 0.438 | 1.903 | 0.509 | 0.686 |
Total Current Liabilities
| 8.418 | 8.636 | 7.303 | 9.765 | 9.508 | 2.552 | 2.446 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 14.411 | 15.673 | 16.998 | 16.977 | 19.882 | 2.85 | 0.159 |
Deferred Revenue Non-Current
| 0.646 | 0 | 55.433 | 0.007 | 0.234 | 0 | 0.201 |
Deferred Tax Liabilities Non-Current
| 1.562 | 1.767 | 1.973 | 2.44 | 2.669 | 0 | -0.159 |
Other Non-Current Liabilities
| 0.114 | 0.112 | -55.207 | 0.347 | 1.995 | 0.597 | 0.207 |
Total Non-Current Liabilities
| 16.733 | 17.552 | 19.197 | 19.771 | 24.78 | 3.447 | 0.408 |
Total Liabilities
| 25.151 | 26.188 | 26.5 | 29.536 | 34.288 | 5.999 | 2.854 |
Equity: | |||||||
Preferred Stock
| 54.655 | 70.59 | 55.175 | 42.651 | 0 | 0 | 0.577 |
Common Stock
| 3.09 | 20.75 | 18.164 | 15.257 | 11.9 | 11.9 | 11.9 |
Retained Earnings
| -57.745 | -70.634 | -55.207 | -42.649 | 0 | -0.001 | -1.865 |
Accumulated Other Comprehensive Income/Loss
| -57.67 | -70.59 | -55.175 | -42.651 | -28.637 | 1.951 | -0.577 |
Other Total Stockholders Equity
| 89.142 | 83.716 | 80.578 | 62.682 | 47.701 | 47.544 | 48.832 |
Total Shareholders Equity
| 31.472 | 33.832 | 43.535 | 35.29 | 30.964 | 61.394 | 58.867 |
Total Equity
| 31.472 | 33.832 | 43.535 | 35.29 | 30.964 | 61.394 | 58.867 |
Total Liabilities & Shareholders Equity
| 56.623 | 60.02 | 70.035 | 64.826 | 65.252 | 67.393 | 61.721 |